Calistoga raises $21 million

Calistoga (Seattle, Wash.) raised $21 million in a series A round led by Frazier Healthcare Ventures. Alta Partners; Three Arch Partners; and Amgen Ventures also participated. Calistoga is a spinout of Icos, which was recently acquired by Eli Lilly (LLY), and is developing preclinical compounds targeting p110 delta, an isoform of phosphoinositide 3-kinase (PI3K), for cancer, inflammatory and autoimmune indications. ...